RecruitingNot ApplicableNCT06914401

Oxygenation Procedure for Obese Patients During Intubation in the Operating Room

Oxygenation Procedure for Obese Patients Using High Flow Oxygen Therapy Combined With Non-invasive Ventilation During Intubation in the Operating Room: a Randomised Controlled Trial


Sponsor

Clinique Pasteur

Enrollment

124 participants

Start Date

Jun 19, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Obesity is a risk factor for difficult intubation, with an incidence of up to 15.5%, and difficult mask ventilation. Obesity also reduces the functional residual capacity (FRC) of the lungs, the main reservoir of oxygen during apnoea. Complications associated with induction and intubation in the operating room are more frequent in obese patients. Preoxygenation is a cornerstone in the management of patients at risk of desaturation during induction. The study aims to compare two oxygenation strategies , in obese patients. Oxygenation using a combination of NIV (Non Invasive Ventilation) and HFNO (High Flow Nasal Oxygen) compared with NIV alone in the operating room for induction of general anaesthesia with orotracheal intubation.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called NIV (Non Invasive Ventilation) and a procedure called NIV (Non Invasive Ventilation) and HFNO (High Flow Nasal Oxygen) for people with anesthesia induction. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURENIV (Non Invasive Ventilation) and HFNO (High Flow Nasal Oxygen)

Combination of two procedures Preoxygenation prior to intubation with NIV (Non Invasive Ventilation) and HFNO (High Flow Nasal Oxygen). During intubation, NIV is stopped and apneic oxygenation is maintained with HFNO

PROCEDURENIV (Non Invasive Ventilation)

Single procedure Preoxygenation prior to intubation with NIV (Non Invasive Ventilation).


Locations(5)

CHU Clermont Ferrand - Site Estaing

Clermont-Ferrand, France

Clinique Honoré Cave

Montauban, France

Hôpital Saint Eloi - CHU Montpellier

Montpellier, France

Clinique Mutualiste La Sagesse

Rennes, France

Clinique Pasteur

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06914401


Related Trials